BMS piloting app to improve clinical trial design with patient insight

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/Preto_perola)
(Image: Getty/Preto_perola)
Bristol-Myers Squibb is conducting a pilot program through which it will use GRYT Health’s mobile app to collect real-world data – with the goal of improving clinical trial design and patient wellbeing.

GRYT Health is a connected health start-up founded in 2016 by cancer survivors and caregivers. The company’s Stupid Cancer app connects cancer patients and caregivers across the US.

By partnering with the Rochester, NY-based startup, Bristol-Myers Squibb (BMS) will be able to collect de-identified patient data and insights to better inform clinical trial design.

“The voice of the patient is really important to BMS as we think about our clinical programs as well as our support services,” ​said Kate Owen, head of global clinical operations at BMS.

“Through this pilot with GRYT and the Stupid Cancer app, we hope to gain insights from relevant patient and caregiver input on burden of disease and current therapy outside of traditional clinical and patient-reported outcomes,”​ Owen told us.

“This is another way for us to build upon our foundation of patient experience data to inform our trial and protocol designs,” ​she added.

Dave Fuehrer, CEO and co-founder of GRYT Health said the company will work with BMS to help expand existing insights around the clinical trial experience and uncover the values and needs that drive patient behavior.

“GRYT is able to generate real-time and longitudinal insights about specific sub-populations relevant to a clinical trial by inviting patients and caregivers to have a voice,” ​Fuehrer said.

Additionally, because of the company has established relationships with participants, it is also able to reconnect with follow-up questions and future activities, he told us.

Since launching October 2017, the Stupid Cancer app has seen a quarter of a million user interactions and more than 300,000 actively engaged patients.

Insights generated from the pilot will inform future plans, Fuehrer said, noting that it is too early at this point to comment on what that would look like.

The Stupid Cancer App is available for free download for iOS devices and will be available for Android in April 2018.

Related news

Show more

Related products

RACE Act Prompts Pediatric Oncology Trials

RACE Act Prompts Pediatric Oncology Trials

PRA Health Sciences | 04-May-2020 | Technical / White Paper

Many providers prescribe drugs off-label to pediatric patients, even though there have been few pediatric trials for many of these drugs. In response,...

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q2 Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Related suppliers

Follow us

Products

View more

Webinars